PKCλ in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity-Reference-Cited by-同舟云学术

PKCλ in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity

Published:2003-09-15 Issue:6 Volume:112 Page:935-944
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Matsumoto Michihiro,Ogawa Wataru,Akimoto Kazunori,Inoue Hiroshi,Miyake Kazuaki,Furukawa Kensuke,Hayashi Yoshitake,Iguchi Haruhisa,Matsuki Yasushi,Hiramatsu Ryuji,Shimano Hitoshi,Yamada Nobuhiro,Ohno Shigeo,Kasuga Masato,Noda Tetsuo

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference46 articles.

1. Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling

2. Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Downregulation of PRKCI inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway;Frontiers in Oncology;2024-07-02

2. The Role of Acyl-CoA Synthetase 1 in Bioactive Lipid Accumulation and the Development of Hepatic Insulin Resistance;Nutrients;2024-03-29

3. Physiological and pathophysiological actions of insulin in the liver;Endocrine Journal;2024

4. Effects of Perilla Seed Meal on Productive Performance, Egg Quality, Antioxidant Capacity and Hepatic Lipid Metabolism of Wenchang Breeder Hens;Animals;2023-11-20

5. Hepatic FASN deficiency differentially affects nonalcoholic fatty liver disease and diabetes in mouse obesity models;JCI Insight;2023-09-08